236 related articles for article (PubMed ID: 25658478)
1. Pulmonary nodule characterization, including computer analysis and quantitative features.
Bartholmai BJ; Koo CW; Johnson GB; White DB; Raghunath SM; Rajagopalan S; Moynagh MR; Lindell RM; Hartman TE
J Thorac Imaging; 2015 Mar; 30(2):139-56. PubMed ID: 25658478
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla.
Ohba Y; Nomori H; Mori T; Shiraishi K; Namimoto T; Katahira K
Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):108-14. PubMed ID: 21471253
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
4. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
Stolzmann P; Veit-Haibach P; Chuck N; Rossi C; Frauenfelder T; Alkadhi H; von Schulthess G; Boss A
Invest Radiol; 2013 May; 48(5):241-6. PubMed ID: 23070096
[TBL] [Abstract][Full Text] [Related]
5. British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
Callister ME; Baldwin DR; Akram AR; Barnard S; Cane P; Draffan J; Franks K; Gleeson F; Graham R; Malhotra P; Prokop M; Rodger K; Subesinghe M; Waller D; Woolhouse I; ;
Thorax; 2015 Aug; 70 Suppl 2():ii1-ii54. PubMed ID: 26082159
[No Abstract] [Full Text] [Related]
6. Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.
Graham RN; Baldwin DR; Callister ME; Gleeson FV
Br J Radiol; 2016; 89(1059):20150776. PubMed ID: 26781558
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives.
Sayyouh M; Vummidi DR; Kazerooni EA
Expert Opin Med Diagn; 2013 Nov; 7(6):629-44. PubMed ID: 24175679
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced computed tomography for the diagnosis of solitary pulmonary nodules: a systematic review and meta-analysis.
Weir-McCall JR; Joyce S; Clegg A; MacKay JW; Baxter G; Dendl LM; Rintoul RC; Qureshi NR; Miles K; Gilbert FJ
Eur Radiol; 2020 Jun; 30(6):3310-3323. PubMed ID: 32060716
[TBL] [Abstract][Full Text] [Related]
9. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Lohrmann C; Weber WA
Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
[TBL] [Abstract][Full Text] [Related]
10. LUCIS: lung cancer imaging studies.
Harders SW
Dan Med J; 2012 Nov; 59(11):B4542. PubMed ID: 23171752
[TBL] [Abstract][Full Text] [Related]
11. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
12. Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
Nie Y; Li Q; Li F; Pu Y; Appelbaum D; Doi K
J Nucl Med; 2006 Jul; 47(7):1075-80. PubMed ID: 16818939
[TBL] [Abstract][Full Text] [Related]
13. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions.
Erasmus JJ; Connolly JE; McAdams HP; Roggli VL
Radiographics; 2000; 20(1):43-58. PubMed ID: 10682770
[TBL] [Abstract][Full Text] [Related]
14. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.
Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
16. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
17. Subsolid pulmonary nodule management and lung adenocarcinoma classification: state of the art and future trends.
Godoy MC; Truong MT; Sabloff B; Naidich DP
Semin Roentgenol; 2013 Oct; 48(4):295-307. PubMed ID: 24034262
[No Abstract] [Full Text] [Related]
18. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R
Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
20. Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.
Pasha AK; Walsh TK; Ampel NM
Lung; 2015 Oct; 193(5):863-4. PubMed ID: 26202257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
